Showing posts with label LGV. Show all posts
Showing posts with label LGV. Show all posts

Tuesday, December 22, 2015

Asymptomatic Lymphogranuloma Venereum in Men who Have Sex with Men, United Kingdom

Abstract
We investigated prevalence of lymphogranuloma venereum (LGV) among men who have sex with men who were tested for chlamydia at 12 clinics in the United Kingdom during 10 weeks in 2012. Of 713 men positive for Chlamydia trachomatis, 66 (9%) had LGV serovars; 15 (27%) of 55 for whom data were available were asymptomatic.

Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) caused by the L1, L2, and L3 serovars of Chlamydia trachomatis (CT). An LGV outbreak among men who have sex with men (MSM) first reported in the Netherlands in 2003 has since spread across other industrialized countries (1). Cases are typically seen among white, HIV-positive MSM who report unprotected anal intercourse, other high-risk behaviors, and STI co-infection and who commonly have symptoms of proctitis (i.e., rectal pain, rectal discharge, bloody stools, constipation, and tenesmus) (2).

The United Kingdom now has the largest documented outbreak of LGV among MSM worldwide (3,4). Infection control in England has relied on CT DNA typing and treatment of symptomatic MSM who have CT-positive rectal infections and their contacts, as well as health promotion. These measures were supported by a large prospective study in the United Kingdom during 2006–2007 that reported <6% of LGV CT infections were asymptomatic (5). However, studies in the Netherlands and Germany, and a smaller UK study, have reported higher proportions (17%–53%) of asymptomatic infection (6–8). We reinvestigated the prevalence of asymptomatic LGV CT infection among MSM in the United Kingdom to assess whether it may be sustaining the current epidemic.

Below:  Figure. Data analysis flowchart for univariable and multivariable analyses of symptomatic lymphogranuloma venereum (LGV) versus non-LGV Chlamydia trachomatis (CT) infection (Table 1) and asymptomatic LGV versus non-LGV CTinfection (Table 2) in men who have sex with men, United Kingdom*Patients from Glasgow were excluded from risk factor analyses because they do not routinely report to the Genitourinary Medicine Clinic Activity Dataset.



Full article at:   http://goo.gl/NJEfPA

By:   Cara Saxon, Gwenda Hughes, Catherine Ison, and for the UK LGV Case-Finding Group
Author affiliations: Author affiliation: Public Health England, London, UK
  


Thursday, December 3, 2015

Rapid Increase in Lymphogranuloma Venereum in Men Who Have Sex with Men, United Kingdom, 2003 to September 2015

United Kingdom (UK) national data show a sharp increase in diagnoses of lymphogranuloma venereum (LGV) since 2012. Most cases are in men who have sex with men (MSM) living in London, with high rates of co-infection with HIV and other sexually transmitted infections. In light of these data, and the recent finding that one quarter of LGV infections may be asymptomatic, clinicians should be vigilant in testing for LGV, including in asymptomatic HIV-positive MSM.

Laboratory diagnoses of lymphogranuloma venereum (LGV) in the United Kingdom (UK) declined between 2010 and 2012, but the most recent data show near doubling of cases since 2012 to unprecedented levels in 2014 (679 cases). This trend has continued into 2015, with 683 cases diagnosed by 30 September. In 2014, most cases were in men who have sex with men (MSM) and around three quarters were HIV-positive. Here we report national surveillance data showing trends in LGV diagnoses in the UK from 2003 to September 2015

Below:  Number of cases diagnosed with lymphogranuloma venereum, per quarter, United Kingdom, 2003 to end September 2015 (n=4,124)


Characteristics of MSM patients from STBRU laboratory reports matched to GUMCADv2 dataset, United Kingdom, 2014 (n=434)


CharacteristicsNumberPercentage
Total number of patientsa434100
Ageb
Median (IQR)3731–44
16–24205
25–3414634
35–4416538
45–548620
55–64123
≥652< 1
Other STI or blood borne virus infection diagnosed in 2014c
Gonorrhoea21950
Syphilis7618
Genital herpes368
Genital warts (Condyloma acuminata)266
Hepatitis C133
HIV status
Positive32174
Negative or unknown11326
Proximity of HIV diagnosis to LGV diagnosisb
HIV > 3 months before LGV23473
HIV 0–3 months before LGV309
Same date4915
HIV 0–3 months after LGV52
HIV > 3 months after LGV31
Area of patient residence
London32374
Manchester184
Brighton72
Birmingham72
Other7918
Country of birthb
United Kingdom23957
Outside United Kingdom17743
Ethnicityb
White32077
Asian164
Black205
Mixed287
Other297

GUMCADv2: Genitourinary Medicine Clinic Activity Dataset; IQR: interquartile range; LGV: lymphogranuloma venereum; MSM: men who have sex with men; STBRU: sexually transmitted bacteria reference unit; STI: sexually transmitted infection.
a Of 677 positive LGV test results in 2014, 440 were successfully matched to GUMCADv2. Six of these were excluded because they were recorded as female or heterosexual in GUMCADv2, leaving 434 matched patients.
b For patients with information available.
c All other STI diagnoses were new except for 14 recurrent cases of genital herpes and 17 recurrent cases of genital warts.


Full article at:  http://goo.gl/4ms65E

By:  T Childs 1 , I Simms 1 , S Alexander 2 , K Eastick 3 , G Hughes 1 , N Field 1 4
1. HIV and STI Department, Public Health England Health Protection Services, Colindale, United Kingdom
2. Sexually Transmitted Bacteria Reference Unit, Public Health England Reference Microbiology Services, Colindale, United Kingdom
3. Scottish Bacterial Sexually Transmitted Infections Reference Laboratory, Edinburgh Royal Infirmary, Edinburgh, United Kingdom
4. Department of Infection and Population Health, University College London, London, United Kingdom